China Mengniu Dairy Co. Ltd.

China Mengniu Dairy Co. Ltd. Takeaways from Mengniu visits in Beijing and impact of new government measures We believe the latest government measures aimed at tightening dairy product supervision will help Mengniu to gain share from smaller players as it already has upstream investments and quality tracking systems in place. We recently visited Mengniu s production plant in Beijing and met Mengniu's head of sales and Mengniu s largest distributor in China. Main takeaways from our visit are i) Mengniu's sales momentum has accelerated in recent months, in particular for higher margin products; ii) distribution reach is getting stronger with c10% addition to distributors this year. Upstream investment now mandatory: According to a statement posted on the central government website on 21 June, China now requires baby formula powder producers to build and control their own farms. Mengniu already satisfies the latest requirement (our recent note The consolidator highlights Mengniu upstream investments) and has no plans for further upstream investments, according to management. Yashili is already building a dairy processing plant in New Zealand. Real-time tracking system: Xinhua news agency reported on 19 June that the government is looking to introduce a real-time tracking system for baby formula. Mengniu management notes that the company is well placed to comply with regulations, as the company already has tracking systems in place to monitor quality from source of milk to point of sale. Bridge loan financing: According to management, the company has secured a 1 year bridge loan financing (RMB9bn) at ~1.6% to finance Yashili acquisition. In the longer term, we expect the company to borrow at a higher range of 3% to 5%. If Mengniu secures a 3% rate, we expect a +15.6% impact to 2014 earnings from Yashili acquisition. Higher margin product sales momentum strong. Our meetings with Mengniu s head of sales and largest distributor supports our view that Mengniu's sales momentum has accelerated in recent months, in particular for higher margin products. China Mengniu Dairy Co. Ltd. (Reuters: 2319.HK, Bloomberg: 2319 HK) Rmb in mn, year-end Dec FY11A FY12A FY13E FY14E FY15E Revenue (Rmb mn) 37,388 36,080 41,615 48,777 56,612 Net Profit (Rmb mn) 1,589 1,257 1,557 2,094 2,611 EPS (Rmb) 0.90 0.71 0.88 1.18 1.48 Recurring EPS (Rmb) 0.90 0.71 0.88 1.18 1.48 DPS (Rmb) 0.20 0.16 0.19 0.26 0.32 Revenue growth (%) 23.5% (3.5%) 15.3% 17.2% 16.1% Net Profit growth (%) 28.4% (20.9%) 23.8% 34.5% 24.6% Recurring profit growth 28.4% (20.9%) 23.8% 34.5% 24.6% EPS growth (%) 26.3% (20.9%) 23.8% 34.5% 24.6% ROE 15.0% 10.5% 11.9% 14.3% 15.8% ROA 8.5% 6.2% 7.2% 8.7% 9.6% P/E (x) 22.6 28.8 23.3 17.3 13.9 P/BV (x) 3.2 2.9 2.6 2.3 2.1 EV/EBITDA (x) 11.6 13.1 10.6 8.2 6.4 Dividend Yield 1.0% 0.8% 0.9% 1.3% 1.6% Source: Company data, Bloomberg, J.P. Morgan estimates. Overweight 2319.HK, 2319 HK Price: HK$25.90 Price Target: HK$30.50 China Consumer Ebru Sener Kurumlu AC Shen Li, CFA (852) 2800 8523 shen.w.li@jpmorgan.com Henry Tan (852) 2800-8559 henry.wd.tan@jpmorgan.com J.P. Morgan Securities (Asia Pacific) Limited Price Performance 30 26 HK$ 22 18 Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 2319.HK share price (HK$) MSCI-Cnx (rebased) YTD 1m 3m 12m Abs 15.9% -1.5% 23.3% 28.2% Rel 33.9% 12.7% 37.8% 29.4% Company Data Shares O/S (mn) 1,768 Market Cap (Rmb mn) 36,274 Market Cap ($ mn) 5,903 Price (HK$) 25.90 Date Of Price 25 Jun 13 Free Float(%) 80.0% 3M - Avg daily volume (mn) 6.95 3M - Avg daily value (HK$ 173.14 mn) 3M - Avg daily value ($ mn) 22.3 MSCI-Cnx 5248.39 Exchange Rate 7.76 Fiscal Year End Dec See page 9 for analyst certification and important disclosures, including non-us analyst disclosures. J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. www.jpmorganmarkets.com

Company Description P&L sensitivity metrics for FY13E EBIT EPS impact (%) impact (%) Mengniu is a leading dairy producer in ASP assumption China. Its major products include liquid Impact of a 0.5% increase 5.9% 5.3% milk product and ice cream. In 2008, it Raw milk cost assumption ranked No.1 in the sectors of liquid milk, Impact of a 1% increase -9.3% -8.3% yogurt and ice cream in China dairy Selling expense as % of sales assumption industry. Impact of a 0.5% increase -11% -9.9% Source: J.P. Morgan estimates. 2012 Revenue Breakdown Price target and valuation analysis Ice cream 9% Other products 1% Our Jun-14 price target of HK$30.5 is based on 0.9x PEG, a discount to the 1x we use for other China consumer staples to reflect higher system risk for the dairy industry, with a two-year (2014-2016) EPS CAGR of c26%. We are using PEG in order to capture earnings growth prospects. Source: Company. Liquid milk 90% EPS J.P. Morgan vs consensus J.P. Morgan Consensus FY13E 0.88 0.89 FY14E 1.18 1.12 FY15E 1.48 1.39 Source: Bloomberg, J.P. Morgan estimates Target PEG 0.9 2013-15E EPS CAGR 26% Implied Jun-14 target PE (x) 23.4 Jun-14 EPS (CNY) 1 Target price (HK$) 30.5 Key risks to our price target are higher-than-expected A&P spending, shortage of raw milk supply in China and slower momentum in Mengniu s high-end products. Peer comparison valuations Company Ticker Rating PT Price Mkt Cap P/E P/B (HK$) (HK$) (USD mn) 2012 2013 2014E 2013E 2014E China Food sector China Mengniu Dairy 2319 HK OW 30.5 25.9 6,056 28.9 23.3 17.3 2.9 2.6 Tingyi 322 HK UW 14.2 18.7 13,502 37.7 31.9 25.5 5.3 4.8 Want Want 151 HK N 9.5 10.0 17,121 30.9 24.9 20.2 10.7 9.4 Tsingtao Brewery 168 HK UW 36.0 50.7 8,413 30.8 27.0 23.0 4.3 3.8 Uni-president China 220 HK N 8.0 7.7 3,550 25.5 20.3 16.8 2.8 2.5 Sector average 30.8 25.5 20.6 5.2 4.6 Source: Bloomberg, J.P. Morgan estimates. Share prices are as of close of 25 Jun, 2013 2

Government tightens supervision over baby formula Upstream investments now mandatory for baby formula producers According to a statement posted on the central government website on 21 June 2013, China now requires baby formula powder producers to build and control their own dairy farms. The statement further stated that powder producers need to: 1) set up an electronic data record system of the entire production and sales process; 2) Create a food safety management division and assign specially-trained safety staff. The government will also implement strict approval for new or expanding baby formula projects. Our talks with industry contacts and Mengniu s management indicate that this move is targeted at local firms who do not operate farms or factories but instead have their products produced at contract manufacturing facilities overseas. We note that CCTV has run stories regarding concerns on the safety of formula milk imported by these firms. We also note that in early June, Premier Li Keqiang spoke about improving the monitoring of the quality of imported milk powder in an address to the state council. Mengniu already satisfies the latest requirement, according to the management. As mentioned in our recent note The consolidator, Mengniu has invested in a series of upstream initiatives with self-built large scale ranches. Yashili is already building a processing plant in New Zealand. Mengniu states that there are no plans for further upstream investments this point in time. Real-time tracking system for baby formulae Xinhua news agency published an article (citing the Ministry of Industry and Information Technology) on 19 June 2013 stating that China is looking to introduce a real-time tracking system for baby formula this year. This relates to the supervision of the sale of infant formula on the Internet. Milk producers, transporters or collection stations that failed to meet safety standards will be banned and violators of safety laws strictly punished. Mengniu management states that if this law is passed, the company is well placed to comply with regulations, as the company already has tracking systems in place to monitor quality from source of milk to point of sales. It believes smaller players will not have the financial resources to meet this requirement. Bride loan financing secured at low interest rates According to management, the company has secured a 1 year bridge loan financing (RMB9bn) from HSBC and SCB at ~1.6% to finance Yashili acquisition. In the longer term, we expect the company to borrow at a higher range of 3% to 5%. If Mengniu secures a 3% rate, we expect a +15.6% impact to 2014 earnings from 3

Yashili acquisition. In the table below, we provide a sensitivity analysis on the impact of the funding cost on earnings. Table 1: Sensitivity Analysis on impact of funding costs on earnings Funding cost Yashili acquisition s impact on Mengniu's 2014 Earnings 1.6% 21.6% 2.0% 19.9% 2.5% 17.7% 3.0% 15.6% 5.0% 7.1% Source: J.P. Morgan estimates. Mengniu s market visit detailed meeting notes We visited Mengniu s production plant in Beijing, spoke with the Head of Sales, and visited Mengniu's largest distributor in China. Main takeaways from our visit are i) Mengniu's sales momentum has accelerated in recent months, in particular for higher margin products; and ii) distribution reach is getting stronger with c10% addition to distributors this year. Detailed notes are available below: Plant visit We visited Mengniu s Beijing production plant. This was located on the outskirts of the city centre, and about two hours away from the farm according to management (which was further away from city centre), and two hours away from the city centre. After milk is collected from the farmers and transported to the production plants, it will have to pass through a detection tank which is configured to inspect if the milk meets quality (e.g. fat, protein) and safety standards (e.g. microbe count, somatic count). After the milk passes the inspection tests, it will be stored in tanks or silos along different phases of the milk processing line - these inter processing tanks are automated into the processing line. Within the milk manufacturing line, there are two key processes: (1) Sterilization to reduce bacteria organisms; and (2) dehydrating + filtration to reduce water content and fat particles. In this process, we note centralized IT systems which will constantly monitor the quality and safety standards of the milk. Once the product manufacturing process is finished, the milk passes to the filling and packaging process. Standard processes produce milk with a shelf life of ~15 days, whilst aseptic processing produces milk with a shelf life ~30 to ~90 days. 60% of the packaging machines are supplied by Tetra Pak (machines churn 40k packets of milk every hour) and 20% of the packaging machines are supplied by Greatview (machines churn 20k packets of milk every hour). According to management, although Tetra Pak has the most productive machines by a stretch, Mengniu uses other suppliers to diversify their supplier dependence. Mengniu believes that the quality of their milk was higher than competitors. Mengniu highlights that the most notable difference between their milk and the 4

competitor milk was that Mengniu s liquid milk feels clear when consumers drink it, and competitor s milk still contain some small particles ( fat golubes ) which can be tasted by consumer. We note that the R&D department is also located within the plant premises. We did not see any Arla products manufactured in the plant. According to management, Mengniu currently imports Arla products to sell locally, as Arla products are not produced domestically. There are no plans in the near future to produce Arla products locally. Meeting with Head of Sales We met with Mengniu's head of sales, Mr. Gao. In the meeting the company indicated that sales grew mid teens in 2013 YTD, and shared that growth accelerated in April and May 2013. Mr. Gao believes this is because consumer confidence in dairy products have returned in the last two months. Management indicates that Mengniu has been the biggest beneficiary of this restoration in confidence and that the company has further gained market share of +2ppt to close to 25% in 1Q13 (up from around 23% in 2012). The company shared the following commentaries at a product level: "Star brands" have been driving this growth in 2013 YTD: You Yi C, Milk Deluxe, Latte are all growing at decent double digit levels. "Backbone" products have also achieved decent growth in 2013 YTD: Suan Suan Ru is growing at mid to high single digit growth. The company continued to emphasize that they will focus on higher margin products going forward. The minimum GPM for new product launches is 30%. Mr Gao indicates that since the 5 year strategic plan was implemented in end-12, the organization has been operating more efficiently. Mr Gao believes that this plan is the most concrete and detailed plan to date for Mengniu and there is huge buy-in from around the organization. Mengniu has already enjoyed quick wins in cost savings in 2013 YTD as a result of the deployment of the strategic plan. In particular, the integration of the sales and marketing resources for various product categories, lower SKUs and brands has resulted in marketing expenses (as a % of sales) to decrease. The company has a target to increase number of POS by 30% to 500k in 2013, and indicates this is well on track. The company utilizes mainly distributors for sales (~80% of total) currently and is looking to move towards more direct sales (~remaining 20%). The company estimates that the benefits of having more control over point of sales/ inventory levels would yield savings. This would outweigh the costs of deploying more direct sales resources. 5

The company has 3k distributors currently, and is looking to increase that by a net ~10% this year. At the same time, it is looking to drop smaller distributors who are under-performing - this adjustment will be a gradual one according to the company. The company continues to emphasize that food safety remains high on management's agenda and that they are working with regulators continuously on boosting industry standards. Arla products have been on sale for ~6 months now on a relatively small scale. Arla products sold in China include pure milk, milk powder, butter and cheese. Danone currently has operations in Shanghai, Beijing and Guangzhou and will be leveraging on Mengniu's nationwide distribution reach to extend their sales into other parts of China. Meeting with Mengniu's largest distributor We met CEO of Mengniu's largest distributor in China. The CEO is also chairman of a customer/ distributor committee set up by Mengniu and is invited to Mengniu's management meetings. The distributor is based in Beijing, and has been an exclusive distributor of Mengniu's products for 14 years. The company employs 1k employees and focuses on liquid normal temperature milk. The CEO highlighted that sales have significantly recovered in 2013 YTD, growing low teens (vs. flat in 2012). In particular, he noted that the Modern Dairy and Danone transactions have provided a notable momentum to growth. Subsequent to the announcements in early/ mid May, sales were up 5% relative to Mar/Apr 13. He believes that this is recognition from consumers on Megniu's efforts on ensuring food safety. He believes the safety concerns on milk quality were valid for milk powder but over-played by the media on other dairy categories. As a result, he believes the "worst is over" and forecasts mid teens growth for FY2013. The distributor also shared that high end premium milk continued to grow faster than other categories. The distributor highlights that there were a few notable differences in distribution strategy/ structure between Mengniu and main competitors that provides Mengniu with a significant competitive advantage: Mengniu has the lowest turnover days in the nation. The distributor's inventory turnover days were 12x (compared to 21x for Mengniu and 39x for Yili). Mengniu's scale advantages result in lower distribution costs. As volumes were higher, Mengniu incurs lower distribution costs per unit This scale advantage also allows Mengniu to fulfill higher % of orders compared to their competitors. According to the distributor, Mengniu fulfills very high % of sales orders, compared with much lower levels by competitors. As orders for 6

competitors were usually in lower volumes, competitors would typically consolidate two/ three orders in one delivery, to save transportation and logistics costs which can be very significant. This causes a delay in delivery response time, and results in competitors being unable to fulfill orders. As a result, Mengniu's scale advantage allows them to pay lower concessionaire rates and get allocated more shelf space. Mengniu's distributors also have to manage their own costs, while some of the competitors distributors costs are borne centrally by the brand and hence higher distribution costs. 7

China Mengniu Dairy Co. Ltd.: Summary of Financials Income Statement Cash flow statement Rmb in millions, year end Dec FY11 FY12 FY13E FY14E FY15E Rmb in millions, year end Dec FY11 FY12 FY13E FY14E FY15E Revenues 37,388 36,080 41,615 48,777 56,612 PBT 2,061 1,685 2,099 2,909 3,677 % change Y/Y 23.5% (3.5%) 15.3% 17.2% 16.1% Depr. & amortization 864 1,009 1,193 1,333 1,434 Gross Profit 9,592 9,055 10,605 12,766 15,092 Change in working capital 38 (68) 86 96 109 % change Y/Y 23.2% (5.6%) 17.1% 20.4% 18.2% Tax & Other (442) (627) (428) (587) (802) Gross margin 25.7% 25.1% 25.5% 26.2% 26.7% Cash flow from operations 2,520 1,999 2,950 3,751 4,418 Other operating income 296 257 250 293 340 EBITDA 2,760 2,503 3,081 3,892 4,692 Capex (2,484) (2,658) (2,350) (2,300) (2,000) % change Y/Y 27.3% (9.3%) 23.1% 26.3% 20.6% Sale of assets - - - - - EBITDA Margin 7.4% 6.9% 7.4% 8.0% 8.3% Acquisition of subsidiaries/intangibles (17) (153) (2,512) 0 0 EBIT 1,896 1,494 1,888 2,559 3,258 Other 856 (429) 113 122 177 % change Y/Y 30.3% (21.2%) 26.3% 35.5% 27.3% Cash flow from investing (1,645) (3,239) (4,749) (2,178) (1,823) EBIT Margin 5.1% 4.1% 4.5% 5.2% 5.8% Net Interest 112 177 78 87 142 Equity raised/(repaid) 521 12 0 0 0 Share of JVs 52 14 133 264 277 Debt raised/(repaid) (450) (287) 0 550 0 Other non operating income - - - - - Dividends paid (331) (421) (275) (342) (460) Earnings before tax 2,061 1,685 2,099 2,909 3,677 Other 22 (35) 0 0 0 % change Y/Y 34.0% (18.2%) 24.6% 38.6% 26.4% Cash flow from financing (238) (731) (275) 208 (460) Tax (276) (245) (315) (465) (625) as % of EBT 13.4% 14.6% 15.0% 16.0% 17.0% FX gain/(loss) (52) (2) 0 0 0 Minorities (195) (182) (227) (349) (442) Net change in cash 585 (1,974) (2,074) 1,781 2,135 Net income (reported) 1,589 1,257 1,557 2,094 2,611 Ending cash 4,360 2,386 870 2,650 4,236 % change Y/Y 28.4% (20.9%) 23.8% 34.5% 24.6% DPS 0.20 0.16 0.19 0.26 0.32 Recurring Net Income 1,589 1,257 1,557 2,094 2,611 % change Y/Y 28.4% (20.9%) 23.8% 34.5% 24.6% EPS (reported) 0.90 0.71 0.88 1.18 1.48 % change Y/Y 26.3% (20.9%) 23.8% 34.5% 24.6% Recurring EPS 0.90 0.71 0.88 1.18 1.48 % change Y/Y 26.3% (20.9%) 23.8% 34.5% 24.6% Balance sheet Ratio Analysis Rmb in millions, year end Dec FY11 FY12 FY13E FY14E FY15E Rmb in millions, year end Dec FY11 FY12 FY13E FY14E FY15E Cash and cash equivalents 6,523 5,778 3,704 4,935 7,070 Gross margin 25.7% 25.1% 25.5% 26.2% 26.7% Accounts receivable 836 801 897 1,021 1,157 EBITDA margin 7.4% 6.9% 7.4% 8.0% 8.3% Inventories 1,685 1,420 1,629 1,892 2,181 Operating Margin 5.1% 4.1% 4.5% 5.2% 5.8% Others 1,342 1,521 1,722 1,982 2,267 Net margin 4.3% 3.5% 3.7% 4.3% 4.6% Current assets 10,387 9,521 7,953 9,831 12,675 Recurring net profit margin 4.3% 3.5% 3.7% 4.3% 4.6% Goodwill - - - - - Sales growth 23.5% (3.5%) 15.3% 17.2% 16.1% Intangible assets 707 708 708 708 708 Net profit growth 28.4% (20.9%) 23.8% 34.5% 24.6% Long term investments - - - - - Recurring net profit growth 28.4% (20.9%) 23.8% 34.5% 24.6% Net fixed assets 7,694 8,489 9,660 10,642 11,223 EPS growth 26.3% (20.9%) 23.8% 34.5% 24.6% Other assets 1,261 1,743 1,728 1,713 1,698 Total Assets 20,202 20,539 22,640 25,485 28,895 Interest coverage (x) - - - - - Net debt to equity (48.7%) (39.6%) (21.3%) (26.0%) (33.6%) Liabilities Sales/assets 2.0 1.8 1.9 2.0 2.1 Short-term loans 657 599 599 599 599 Assets/equity 176.7% 170.4% 165.0% 164.8% 164.3% Trade & other payables 3,685 3,679 4,030 4,471 4,956 ROE 15.0% 10.5% 11.9% 14.3% 15.8% Others 2,885 2,703 2,944 3,246 3,578 ROCE 14.5% 10.1% 11.7% 14.1% 15.8% Total current liabilities 7,226 6,981 7,573 8,315 9,133 Long-term debt 0 0 0 0 0 Others 927 938 938 938 938 Total Liabilities 8,153 7,919 8,511 9,254 10,072 Minorities 578 629 856 1,205 1,647 Shareholders' equity 11,471 12,443 13,725 15,477 17,628 BVPS 6.49 7.04 7.77 8.76 9.97 Source: Company reports and J.P. Morgan estimates. 8

Analyst Certification: The research analyst(s) denoted by an AC on the cover of this report certifies (or, where multiple research analysts are primarily responsible for this report, the research analyst denoted by an AC on the cover or within the document individually certifies, with respect to each security or issuer that the research analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect his or her personal views about any and all of the subject securities or issuers; and (2) no part of any of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst(s) in this report. Important Disclosures Client: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as clients: China Mengniu Dairy Co. Ltd.. Company-Specific Disclosures: Important disclosures, including price charts, are available for compendium reports and all J.P. Morgan covered companies by visiting https://mm.jpmorgan.com/disclosures/company, calling 1-800-477-0406, or e-mailing research.disclosure.inquiries@jpmorgan.com with your request. J.P. Morgan s Strategy, Technical, and Quantitative Research teams may screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-0406 or e-mail research.disclosure.inquiries@jpmorgan.com. China Mengniu Dairy Co. Ltd. (2319.HK, 2319 HK) Price Chart Price(HK$) 65 52 39 26 13 0 Oct 06 Jul 07 Apr 08 Jan 09 OW HK$23 UW HK$14.5 Oct 09 Jul 10 Apr 11 OW HK$24 OW HK$25 OW HK$33 OW HK$26 UW HK$18 UW HK$3.8 UW HK$8.1 OW HK$32 OW HK$30 OW HK$26OW HK$30 OW HK$35 OW HK$27 OW HK$28 OW HK$24 OW HK$3 Source: Bloomberg and J.P. Morgan; price data adjusted for stock splits and dividends. Initiated coverage Apr 10, 2008. Jan 12 Oct 12 Jul 13 Date Rating Share Price (HK$) 10-Apr-08 UW 20.35 18.00 21-Sep-08 UW 20.00 3.80 17-Apr-09 UW 12.42 8.10 28-Jun-09 UW 18.60 14.50 09-Sep-09 OW 19.48 23.00 08-Dec-09 OW 28.80 32.00 29-Apr-10 OW 23.55 30.00 01-Sep-10 OW 21.50 26.00 02-May-11 OW 24.25 30.00 31-Aug-11 OW 26.60 35.00 12-Oct-11 OW 25.65 33.00 10-Jan-12 OW 20.20 24.00 10-Feb-12 OW 22.75 27.00 27-Mar-12 OW 21.95 26.00 02-Jul-12 OW 20.35 25.00 28-Aug-12 OW 23.00 28.00 13-Dec-12 OW 20.35 24.00 19-Jun-13 OW 26.85 30.50 Price Target (HK$) The chart(s) show J.P. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire period. J.P. Morgan ratings or designations: OW = Overweight, N= Neutral, UW = Underweight, NR = Not Rated Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe: J.P. Morgan uses the following rating system: Overweight [Over the next six to twelve months, we expect this stock will outperform the average total return of the stocks in the analyst s (or the analyst s team s) coverage universe.] Neutral [Over the next six to twelve months, we expect this stock will perform in line with the average total return of the stocks in the analyst s (or the analyst s team s) coverage universe.] Underweight [Over the next six to twelve months, we expect this stock will underperform the average total return of the stocks in the analyst s (or the analyst s team s) coverage universe.] Not Rated (NR): J.P. Morgan has removed the rating and, if applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a recommendation or a rating. In our Asia (ex-australia) and U.K. small- and mid-cap equity research, each stock s expected total return is compared to the expected total return of a benchmark country market index, not to those analysts coverage universe. If it does not appear in the Important Disclosures section of this report, the certifying analyst s coverage universe can be found on J.P. Morgan s research website, www.jpmorganmarkets.com. Coverage Universe: Sener, Kurumlu Ebru: Ajisen China Holdings Ltd (0538.HK), Belle International Holdings Ltd. (1880.HK), Cafe de Coral Holdings Ltd (0341.HK), China Foods Ltd (0506.HK), China Mengniu Dairy Co. Ltd. (2319.HK), China Resources Enterprise (0291.HK), Chow Tai Fook Jewellery Company Ltd. (1929.HK), Dairy Farm International Holdings Limited (DAIR.SI), Esprit Holdings 9

(0330.HK), Golden Eagle Retail Group Ltd (3308.HK), Hengan International Group Ltd (1044.HK), L'Occitane International SA (0973.HK), Li & Fung (0494.HK), Lifestyle International Holdings (1212.HK), New World Department Stores Ltd (0825.HK), Parkson Retail Group Ltd (3368.HK), Prada S.P.A (1913.HK), Sa Sa International Holdings Limited (0178.HK), Thai Beverage Public Company Ltd. (TBEV.SI), Tibet 5100 Water Resources Holdings Ltd (1115.HK), Tingyi (Cayman Islands) Holding Corp (0322.HK), Tsingtao Brewery - A (600600.SS), Tsingtao Brewery - H (0168.HK), Uni-President China Holdings Ltd (0220.HK), Want Want China Holdings Ltd (0151.HK) J.P. Morgan Equity Research Ratings Distribution, as of March 30, 2013 Overweight (buy) Neutral (hold) Underweight (sell) J.P. Morgan Global Equity Research Coverage 43% 44% 13% IB clients* 54% 47% 38% JPMS Equity Research Coverage 42% 50% 9% IB clients* 74% 64% 57% *Percentage of investment banking clients in each rating category. For purposes only of FINRA/NYSE ratings distribution rules, our Overweight rating falls into a buy rating category; our Neutral rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. Please note that stocks with an NR designation are not included in the table above. Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst or your J.P. Morgan representative, or email research.disclosure.inquiries@jpmorgan.com. Equity Analysts' Compensation: The equity research analysts responsible for the preparation of this report receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues. Registration of non-us Analysts: Unless otherwise noted, the non-us analysts listed on the front of this report are employees of non-us affiliates of JPMS, are not registered/qualified as research analysts under NASD/NYSE rules, may not be associated persons of JPMS, and may not be subject to FINRA Rule 2711 and NYSE Rule 472 restrictions on communications with covered companies, public appearances, and trading securities held by a research analyst account. Other Disclosures J.P. Morgan ("JPM") is the global brand name for J.P. Morgan Securities LLC ("JPMS") and its affiliates worldwide. J.P. Morgan Cazenove is a marketing name for the U.K. investment banking businesses and EMEA cash equities and equity research businesses of JPMorgan Chase & Co. and its subsidiaries. All research reports made available to clients are simultaneously available on our client website, J.P. Morgan Markets. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your sales representative. Options related research: If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options, please contact your J.P. Morgan Representative or visit the OCC's website at http://www.optionsclearing.com/publications/risks/riskstoc.pdf Legal Entities Disclosures U.S.: JPMS is a member of NYSE, FINRA, SIPC and the NFA. JPMorgan Chase Bank, N.A. is a member of FDIC and is authorized and regulated in the UK by the Financial Services Authority. U.K.: J.P. Morgan Securities plc (JPMS plc) is a member of the London Stock Exchange and is authorized and regulated by the Financial Services Authority. Registered in England & Wales No. 2711006. Registered Office 25 Bank Street, London, E14 5JP. South Africa: J.P. Morgan Equities South Africa Proprietary Limited is a member of the Johannesburg Securities Exchange and is regulated by the Financial Services Board. Hong Kong: J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong. Korea: J.P. Morgan Securities (Far East) Ltd, Seoul Branch, is regulated by the Korea Financial Supervisory Service. Australia: J.P. Morgan Australia Limited (JPMAL) (ABN 52 002 888 011/AFS Licence No: 238188) is regulated by ASIC and J.P. Morgan Securities Australia Limited (JPMSAL) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by ASIC and is a Market, Clearing and Settlement Participant of ASX Limited and CHI-X. Taiwan: J.P.Morgan Securities (Taiwan) Limited is a participant of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau. India: J.P. Morgan India Private Limited, having its registered office at J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz East, Mumbai - 400098, is a member of the National Stock Exchange of India Limited (SEBI Registration Number - INB 230675231/INF 230675231/INE 230675231) and Bombay Stock Exchange Limited (SEBI Registration Number - INB 010675237/INF 010675237) and is regulated by Securities and Exchange Board of India. Thailand: JPMorgan Securities (Thailand) Limited is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and Exchange Commission. Indonesia: PT J.P. Morgan Securities Indonesia is a member of the Indonesia Stock Exchange and is regulated by the BAPEPAM LK. Philippines: J.P. Morgan Securities Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Brazil: Banco J.P. Morgan S.A. is regulated by the Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Mexico: J.P. Morgan Casa de Bolsa, S.A. de C.V., J.P. Morgan Grupo Financiero is a member of the Mexican Stock Exchange and authorized to act as a broker dealer by the National Banking and Securities Exchange Commission. Singapore: This material is issued and distributed in Singapore by J.P. Morgan Securities Singapore Private Limited (JPMSS) [MIC (P) 049/04/2013 and 10

Co. Reg. No.: 199405335R] which is a member of the Singapore Exchange Securities Trading Limited and is regulated by the Monetary Authority of Singapore (MAS) and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB Singapore) which is regulated by the MAS. Japan: JPMorgan Securities Japan Co., Ltd. is regulated by the Financial Services Agency in Japan. Malaysia: This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X) which is a Participating Organization of Bursa Malaysia Berhad and a holder of Capital Markets Services License issued by the Securities Commission in Malaysia. Pakistan: J. P. Morgan Pakistan Broking (Pvt.) Ltd is a member of the Karachi Stock Exchange and regulated by the Securities and Exchange Commission of Pakistan. Saudi Arabia: J.P. Morgan Saudi Arabia Ltd. is authorized by the Capital Market Authority of the Kingdom of Saudi Arabia (CMA) to carry out dealing as an agent, arranging, advising and custody, with respect to securities business under licence number 35-07079 and its registered address is at 8th Floor, Al-Faisaliyah Tower, King Fahad Road, P.O. Box 51907, Riyadh 11553, Kingdom of Saudi Arabia. Dubai: JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial Centre - Building 3, Level 7, PO Box 506551, Dubai, UAE. Country and Region Specific Disclosures U.K. and European Economic Area (EEA): Unless specified to the contrary, issued and approved for distribution in the U.K. and the EEA by JPMS plc. Investment research issued by JPMS plc has been prepared in accordance with JPMS plc's policies for managing conflicts of interest arising as a result of publication and distribution of investment research. Many European regulators require a firm to establish, implement and maintain such a policy. This report has been issued in the U.K. only to persons of a kind described in Article 19 (5), 38, 47 and 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (all such persons being referred to as "relevant persons"). This document must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is only available to relevant persons and will be engaged in only with relevant persons. In other EEA countries, the report has been issued to persons regarded as professional investors (or equivalent) in their home jurisdiction. Australia: This material is issued and distributed by JPMSAL in Australia to "wholesale clients" only. This material does not take into account the specific investment objectives, financial situation or particular needs of the recipient. The recipient of this material must not distribute it to any third party or outside Australia without the prior written consent of JPMSAL. For the purposes of this paragraph the term "wholesale client" has the meaning given in section 761G of the Corporations Act 2001. Germany: This material is distributed in Germany by J.P. Morgan Securities plc, Frankfurt Branch and J.P.Morgan Chase Bank, N.A., Frankfurt Branch which are regulated by the Bundesanstalt für Finanzdienstleistungsaufsicht. Hong Kong: The 1% ownership disclosure as of the previous month end satisfies the requirements under Paragraph 16.5(a) of the Hong Kong Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission. (For research published within the first ten days of the month, the disclosure may be based on the month end data from two months prior.) J.P. Morgan Broking (Hong Kong) Limited is the liquidity provider/market maker for derivative warrants, callable bull bear contracts and stock options listed on the Stock Exchange of Hong Kong Limited. An updated list can be found on HKEx website: http://www.hkex.com.hk. Japan: There is a risk that a loss may occur due to a change in the price of the shares in the case of share trading, and that a loss may occur due to the exchange rate in the case of foreign share trading. In the case of share trading, JPMorgan Securities Japan Co., Ltd., will be receiving a brokerage fee and consumption tax (shouhizei) calculated by multiplying the executed price by the commission rate which was individually agreed between JPMorgan Securities Japan Co., Ltd., and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co., Ltd., Kanto Local Finance Bureau (kinsho) No. 82 Participating Association / Japan Securities Dealers Association, The Financial Futures Association of Japan, Type II Financial Instruments Firms Association and Japan Investment Advisers Association. Korea: This report may have been edited or contributed to from time to time by affiliates of J.P. Morgan Securities (Far East) Ltd, Seoul Branch. Singapore: JPMSS and/or its affiliates may have a holding in any of the securities discussed in this report; for securities where the holding is 1% or greater, the specific holding is disclosed in the Important Disclosures section above. India: For private circulation only, not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the course of and for the purposes of their business, habitually invest money. JPMSAL does not issue or distribute this material to members of "the public" as determined in accordance with section 3 of the Securities Act 1978. The recipient of this material must not distribute it to any third party or outside New Zealand without the prior written consent of JPMSAL. Canada: The information contained herein is not, and under no circumstances is to be construed as, a prospectus, an advertisement, a public offering, an offer to sell securities described herein, or solicitation of an offer to buy securities described herein, in Canada or any province or territory thereof. Any offer or sale of the securities described herein in Canada will be made only under an exemption from the requirements to file a prospectus with the relevant Canadian securities regulators and only by a dealer properly registered under applicable securities laws or, alternatively, pursuant to an exemption from the dealer registration requirement in the relevant province or territory of Canada in which such offer or sale is made. The information contained herein is under no circumstances to be construed as investment advice in any province or territory of Canada and is not tailored to the needs of the recipient. To the extent that the information contained herein references securities of an issuer incorporated, formed or created under the laws of Canada or a province or territory of Canada, any trades in such securities must be conducted through a dealer registered in Canada. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed judgment upon these materials, the information contained herein or the merits of the securities described herein, and any representation to the contrary is an offence. Dubai: This report has been issued to persons regarded as professional clients as defined under the DFSA rules. Brazil: Ombudsman J.P. Morgan: 0800-7700847 / ouvidoria.jp.morgan@jpmorgan.com. General: Additional information is available upon request. Information has been obtained from sources believed to be reliable but JPMorgan Chase & Co. or its affiliates and/or subsidiaries (collectively J.P. Morgan) do not warrant its completeness or accuracy except with respect to any disclosures relative to JPMS and/or its affiliates and the analyst's involvement with the issuer that is the subject of the research. All pricing is as of the close of market for the securities discussed, unless otherwise stated. Opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. The recipient of this report must make its own independent decisions regarding any securities or financial instruments mentioned herein. JPMS distributes in the U.S. research published by non-u.s. affiliates and accepts responsibility for its contents. Periodic updates may be provided on companies/industries based on company specific developments or announcements, market conditions or any other publicly available information. Clients should contact analysts and execute transactions through a J.P. Morgan subsidiary or affiliate in their home jurisdiction unless governing law permits otherwise. "Other Disclosures" last revised May 4, 2013. Copyright 2013 JPMorgan Chase & Co. All rights reserved. This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. #$J&098$#*P 11

12